Methods to assess impaired post‐prandial metabolism and the impact for early detection of cardiovascular disease risk
Authors:
Open Access
- 24 July 2009
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 39 (9) , 741-754
Abstract
Post‐prandial lipaemia has emerged as a key contributor to cardiovascular disease (CVD) risk and progression. Specifically, delayed clearance of chylomicrons (CM) and their remnants increase the delivery of triglyceride and cholesteryl ester to the vessel wall and can accelerate the progression of atherosclerosis, which may be particularly pertinent to individuals with insulin resistance and/or obesity. As the number of studies linking post‐prandial metabolism and chronic disease increases, interest has grown in the use of parameters reflecting CM metabolism as a possible indicator of early CVD risk. This, in turn has raised the question of what method might be most appropriate to detect CM and their remnants in plasma accurately. However, the handful of techniques able to measure CM metabolism (triglyceride‐rich lipoprotein fractions; remnant‐lipoprotein cholesterol; retinyl esters, CM‐like emulsion; sodium dodecyl sulphate–polyacrylamide gel electrophoresis; immunoblotting, enzyme‐linked immunoabsorbent assays; C13 breath test; capillary finger prick) differ in their specificity, cost and applicability in research and in the clinical setting. In this review, we explore the scientific and clinical implications of CM methodology to better understand early risk assessment of CVD. We raise ongoing issues of the need to appreciate differential separation of very low‐density lipoprotein and CM fractions, as well as to identify the technical basis for imprecision between assays for apolipoprotein B48. We also highlight emerging issues with respect to the practicality of measuring post‐prandial metabolism in large clinical studies and offer opinions on the appropriateness of existing techniques in this field.Keywords
This publication has 85 references indexed in Scilit:
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Clearance of a 3H-labeled chylomicron-like emulsion following the acute phase of myocardial infarctionInternational Journal of Cardiology, 2004
- Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISAJournal of Lipid Research, 2003
- Retention of fluorescent‐labelled chylomicron remnants within the intima of the arterial wall — evidence that plaque cholesterol may be derived from post‐prandial lipoproteinsEuropean Journal of Clinical Investigation, 1998
- Quantitation of apolipoprotein B-48 in triacylglycerol-rich lipoproteins by a specific enzyme-linked immunosorbent assayBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Asymptomatic Carotid Artery Atherosclerosis in Middle-aged Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Quantification of Postprandial Triglyceride-Rich Lipoproteins in Healthy Men by Retinyl Ester Labeling and Simultaneous Measurement of Apolipoproteins B-48 and B-100Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.Journal of Clinical Investigation, 1986